Literature DB >> 20118381

Influenza vaccines: from surveillance through production to protection.

Pritish K Tosh1, Robert M Jacobson, Gregory A Poland.   

Abstract

Influenza is an important contributor to population and individual morbidity and mortality. The current influenza pandemic with novel H1N1 has highlighted the need for health care professionals to better understand the processes involved in creating influenza vaccines, both for pandemic as well as for seasonal influenza. This review presents an overview of influenza-related topics to help meet this need and includes a discussion of the burden of disease, virology, epidemiology, viral surveillance, and vaccine strain selection. We then present an overview of influenza vaccine-related topics, including vaccine production, vaccine efficacy and effectiveness, influenza vaccine misperceptions, and populations that are recommended to receive vaccination. English-language articles in PubMed published between January 1, 1970, and October 7, 2009, were searched using key words human influenza, influenza vaccines, influenza A, and influenza B.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20118381      PMCID: PMC2843114          DOI: 10.4065/mcp.2009.0615

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  218 in total

1.  A humanized anti-M2 scFv shows protective in vitro activity against influenza.

Authors:  J Gabbard; N Velappan; R Di Niro; J Schmidt; C A Jones; S M Tompkins; A R M Bradbury
Journal:  Protein Eng Des Sel       Date:  2008-12-02       Impact factor: 1.650

Review 2.  Efficacy and effectiveness of influenza vaccination.

Authors:  Kristin L Nichol
Journal:  Vaccine       Date:  2008-09-12       Impact factor: 3.641

Review 3.  Facing the challenges of influenza in healthcare settings: the ethical rationale for mandatory seasonal influenza vaccination and its implications for future pandemics.

Authors:  Jon C Tilburt; Paul S Mueller; Abigale L Ottenberg; Gregory A Poland; Barbara A Koenig
Journal:  Vaccine       Date:  2008-09-12       Impact factor: 3.641

4.  Neuropsychological performance 10 years after immunization in infancy with thimerosal-containing vaccines.

Authors:  Alberto Eugenio Tozzi; Patrizia Bisiacchi; Vincenza Tarantino; Barbara De Mei; Lidia D'Elia; Flavia Chiarotti; Stefania Salmaso
Journal:  Pediatrics       Date:  2009-02       Impact factor: 7.124

Review 5.  Influenza vaccine strain selection and recent studies on the global migration of seasonal influenza viruses.

Authors:  Colin A Russell; Terry C Jones; Ian G Barr; Nancy J Cox; Rebecca J Garten; Vicky Gregory; Ian D Gust; Alan W Hampson; Alan J Hay; Aeron C Hurt; Jan C de Jong; Anne Kelso; Alexander I Klimov; Tsutomu Kageyama; Naomi Komadina; Alan S Lapedes; Yi P Lin; Ana Mosterin; Masatsugu Obuchi; Takato Odagiri; Albert D M E Osterhaus; Guus F Rimmelzwaan; Michael W Shaw; Eugene Skepner; Klaus Stohr; Masato Tashiro; Ron A M Fouchier; Derek J Smith
Journal:  Vaccine       Date:  2008-09-12       Impact factor: 3.641

6.  Effects of annual influenza vaccination on winter mortality in elderly people with chronic heart disease.

Authors:  Cinta de Diego; Angel Vila-Córcoles; Olga Ochoa; Teresa Rodriguez-Blanco; Elisabeth Salsench; Imma Hospital; Ferran Bejarano; M Del Puy Muniain; Mercé Fortin; Montserrat Canals
Journal:  Eur Heart J       Date:  2008-11-08       Impact factor: 29.983

7.  Effectiveness of inactivated influenza vaccines varied substantially with antigenic match from the 2004-2005 season to the 2006-2007 season.

Authors:  Edward A Belongia; Burney A Kieke; James G Donahue; Robert T Greenlee; Amanda Balish; Angie Foust; Stephen Lindstrom; David K Shay
Journal:  J Infect Dis       Date:  2009-01-15       Impact factor: 5.226

8.  Influenza vaccination rates of expectant parents with neonatal intensive care admission.

Authors:  Shetal I Shah; Frances Turcotte; Hong Dao Meng
Journal:  J Matern Fetal Neonatal Med       Date:  2008-10

Review 9.  The problem with Dr Bob's alternative vaccine schedule.

Authors:  Paul A Offit; Charlotte A Moser
Journal:  Pediatrics       Date:  2009-01       Impact factor: 7.124

10.  Guillain-Barré syndrome and influenza virus infection.

Authors:  Valérie Sivadon-Tardy; David Orlikowski; Raphaël Porcher; Tarek Sharshar; Marie-Christine Durand; Vincent Enouf; Flore Rozenberg; Christiane Caudie; Djillali Annane; Sylvie van der Werf; Pierre Lebon; Jean-Claude Raphaël; Jean-Louis Gaillard; Elyanne Gault
Journal:  Clin Infect Dis       Date:  2009-01-01       Impact factor: 9.079

View more
  28 in total

1.  Religion and preventive service use: do congregational support and religious beliefs explain the relationship between attendance and utilization?

Authors:  Maureen R Benjamins; Christopher G Ellison; Neal M Krause; John P Marcum
Journal:  J Behav Med       Date:  2011-02-01

Review 2.  Inactivated split-virion seasonal influenza vaccine (Fluarix): a review of its use in the prevention of seasonal influenza in adults and the elderly.

Authors:  Monique P Curran; Isabel Leroux-Roels
Journal:  Drugs       Date:  2010-08-20       Impact factor: 9.546

3.  Regulation of antinucleoprotein IgG by systemic vaccination and its effect on influenza virus clearance.

Authors:  Mark W Lamere; Amy Moquin; F Eun-Hyung Lee; Ravi S Misra; Patrick J Blair; Laura Haynes; Troy D Randall; Frances E Lund; Denise A Kaminski
Journal:  J Virol       Date:  2011-03-02       Impact factor: 5.103

Review 4.  Hallmarks of CD4 T cell immunity against influenza.

Authors:  K K McKinstry; T M Strutt; S L Swain
Journal:  J Intern Med       Date:  2011-03-25       Impact factor: 8.989

5.  Contributions of antinucleoprotein IgG to heterosubtypic immunity against influenza virus.

Authors:  Mark W LaMere; Ho-Tak Lam; Amy Moquin; Laura Haynes; Frances E Lund; Troy D Randall; Denise A Kaminski
Journal:  J Immunol       Date:  2011-02-25       Impact factor: 5.422

6.  Adjuvant-free immunization with hemagglutinin-Fc fusion proteins as an approach to influenza vaccines.

Authors:  Silvia Loureiro; Junyuan Ren; Pongsathon Phapugrangkul; Camilo A Colaco; Christopher R Bailey; Holly Shelton; Eleonora Molesti; Nigel J Temperton; Wendy S Barclay; Ian M Jones
Journal:  J Virol       Date:  2010-12-29       Impact factor: 5.103

Review 7.  Structural basis of influenza virus neutralization.

Authors:  Thomas Han; Wayne A Marasco
Journal:  Ann N Y Acad Sci       Date:  2011-01-11       Impact factor: 5.691

Review 8.  Intanza (®) 9 µg intradermal seasonal influenza vaccine for adults 18 to 59 years of age.

Authors:  Isabel Leroux-Roels; Françoise Weber
Journal:  Hum Vaccin Immunother       Date:  2013-01       Impact factor: 3.452

9.  Influenza vaccination among cancer survivors: disparities in prevalence between blacks and whites.

Authors:  Kristen A Stafford; John D Sorkin; Eileen K Steinberger
Journal:  J Cancer Surviv       Date:  2013-01-13       Impact factor: 4.442

10.  Serological survey of the novel influenza A H1N1 in inner city Winnipeg, Manitoba, 2009.

Authors:  Laura H Thompson; Salaheddin M Mahmud; Yoav Keynan; James F Blanchard; Joyce Slater; Magdy Dawood; Keith Fowke; Paul Van Caeseele; Marissa Becker
Journal:  Can J Infect Dis Med Microbiol       Date:  2012       Impact factor: 2.471

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.